New eye drops aim to boost blood flow for diabetic retinopathy and glaucoma patients
NCT ID NCT07354477
First seen Jan 26, 2026 · Last updated May 12, 2026 · Updated 16 times
Summary
This early study tests whether QLS-111 eye drops can improve blood flow in the back of the eye for people with diabetic retinopathy or certain types of glaucoma. About 14 participants will use the drops and have their eye blood flow measured over several weeks. The goal is to see if the treatment helps nourish the eye better, not to cure the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN-ANGLE GLAUCOMA (OAG) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University, Dept. of Ophthalmology
RECRUITINGPalo Alto, California, 94303, United States
Conditions
Explore the condition pages connected to this study.